Vice President / Global Head
Takeda Pharmaceuticals, Inc.
boston, Massachusetts
Saileta Prabhu is Vice President and Global Head of Clinical Biomarker Innovation & Development (CBID) department at Takeda. Saileta received her Ph.D. from a joint program in Pharmaceutical Sciences & Chemical Engineering from the Institute of Chemical Technology, Bombay, India. Following her post-doc at Rutgers University, USA she worked at In Vitro Technologies and Sunesis before joining Genentech in 2004. Her department at Genentech was accountable for providing translational and investigative PKPD guidance for Genentech’s protein therapeutics. At Takeda, her group focuses on the biomarker and bioanalytical plans for clinical programs. Over the past two decades, she has worked extensively in the area of antibody-drug conjugates, bispecific antibodies, and drug delivery, and supported the approval of several biologics. Since 2013, Saileta has taught PKPD and drug development at UCSF’s PK course as well as UCSF’s American Course on Drug Development & Regulatory Sciences. Saileta is also a proud recipient of the Rising Star award given by the Healthcare Businesswomen’s Association.
Disclosure information not submitted.
Wednesday, October 19, 2022
9:00 AM – 9:30 AM ET